Bio-AI Health
Goffstown, US · Founded 2020 · Delaware corporation
Founders & leadership
TC
Thomas ColarussoNamed on SEC filing
MV
Mike VergatoNamed on SEC filing
AJ
Alan JerusalmiNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 2 rounds · 2022–2024
▶$500KraisedApr 2024 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedApr 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mike VergatoDirector
- Thomas ColarussoExecutive Officer, Director
- Alan JerusalmiDirector
- Offering amount
- $2.8M
- Amount sold
- $500K
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$3MraisedJan 2024 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedJan 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas ColarussoExecutive Officer, Director
- Mike VergatoDirector
- Alan JerusalmiDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Bio-AI Health raised?
- Bio-AI Health has disclosed $3.5M raised across 2 rounds.
- Where is Bio-AI Health headquartered?
- Bio-AI Health is headquartered in Goffstown, US.